跳至主要内容
临床试验/IRCT20210505051197N1
IRCT20210505051197N1招募中2 期

Study of therapeutic effect of melatonin in patients with COVID-19 : a double-blind randomized clinical trial

Rasht University of Medical Sciences0 个研究点目标入组 96 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • RT-PCR test positive for SARS-CoV-2
  • criteria for patients with moderate symptoms:evidence of lower respiratory disease( dyspnea, Chest compression ?..)
  • oxygen saturation (SpO2) between 90 to 93%
  • lung infiltrates<50%
  • criteria for patients with sever symptoms: Dyspnea
  • respiratory frequency >30 breaths/min
  • oxygen saturation (SpO2) < 90% and PaO2/FiO2 <300 mm Hg
  • lung infiltrates >50%

排除标准

  • patients with mild symptoms
  • hypertension
  • pregnant women
  • those who have already been in clinical trial with other drugs.
  • Age less than 18 years

研究者

发起方
Rasht University of Medical Sciences

相似试验